Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs VanEck Uranium & Nuclear ETF (NLR) Price & Performance

Ginkgo Bioworks Holdings IncTrade
VanEck Uranium & Nuclear ETFTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs VanEck Uranium & Nuclear ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $12.93 (market cap $763.64M), while VanEck Uranium & Nuclear ETF trades at $103.29 (market cap $3.51B). The key difference: VanEck Uranium & Nuclear ETF is far larger — about 4.6× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, VanEck Uranium & Nuclear ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and VanEck Uranium & Nuclear ETF for 8 Days on average.

DNANLR
Market Cap
$763.64M$3.51B
Volume
3,204,177414,516
Sector
HealthSector/Thematic
52-Week High
$15.83$164.37
52-Week Low
$5.48$102.38
Typical Hold Time
7 Days8 Days
Enterprise Value
$865.59M—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $13.04, up 13.69% in the last session, with a bullish technical signal from moving averages. The company maintains strong gross margins at 68.04% but faces significant losses with a -219.6% net income margin. Recent developments include a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnerships expanding genetic testing distribution.

While technical momentum appears positive, fundamental challenges persist with substantial cash burn and declining revenue projections. Analyst sentiment is divided equally between buy, hold, and sell ratings. Investment opportunity lies in the company's strategic partnerships and government contracts, balanced against ongoing profitability concerns and competitive pressures in biotech.

VanEck Uranium & Nuclear ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DNA
47% Buy53% Sell
Avg holding period · 7 Days
NLR
0% Buy100% Sell
Avg holding period · 8 Days

Top news

Latest headlines on both assets

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →

About VanEck Uranium & Nuclear ETF

VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.

Read more on NLR →